VCM
MIRM icon

Voleon Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Voleon Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.7M Sell
82,877
-67,636
-45% -$6.79M 0.18% 123
2026
Q1 		$13.9M Sell
150,513
-22,554
-13% -$2.12M 0.3% 73
2025
Q4 		$13.7M Buy
173,067
+86,538
+100% +$6.21M 0.29% 73
2025
Q3 		$6.34M Buy
+86,529
New +$5.5M 0.15% 138

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voleon Capital Management's MIRM Position: Q2 2026 in Review

Voleon Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 45% in Q2 2026, selling an estimated $6.79M and leaving 82,877 shares worth $9.7M. The position accounts for 0.18% of the portfolio, ranked #123.

Voleon Capital Management first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.9M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Voleon Capital Management held 82,877 shares of Mirum Pharmaceuticals worth $9.7M as of Q2 2026.
  • Voleon Capital Management sold 67,636 Mirum Pharmaceuticals shares in Q2 2026, an estimated $6.79M.
  • Mirum Pharmaceuticals made up 0.18% of Voleon Capital Management's portfolio in Q2 2026, its #123 holding.
  • Voleon Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Mirum Pharmaceuticals position peaked at $13.9M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.